A design strategy of ultrasmall Gd 2 O 3 nanoparticles for T 1 MRI with high performance

It is still a big challenge to design Gd 3+ based nanoparticles (NPs) for T 1 MRI (Magnetic Resonance Imaging) with high performance and clarify the effects of relative time parameters on longitudinal relaxivity r 1 . In this paper, we simulated the influences of different time parameters on the lon...

Full description

Saved in:
Bibliographic Details
Published inNew journal of chemistry Vol. 45; no. 16; pp. 7270 - 7277
Main Authors Yang, Jianfeng, Shan, Pengyuan, Zhao, Qingling, Zhang, Shuquan, Li, Lanlan, Yang, Xiaojing, Yu, Xiaofei, Lu, Zunming, Wang, Ziwu, Zhang, Xinghua
Format Journal Article
LanguageEnglish
Published 26.04.2021
Online AccessGet full text

Cover

Loading…
More Information
Summary:It is still a big challenge to design Gd 3+ based nanoparticles (NPs) for T 1 MRI (Magnetic Resonance Imaging) with high performance and clarify the effects of relative time parameters on longitudinal relaxivity r 1 . In this paper, we simulated the influences of different time parameters on the longitudinal relaxivity of Gd 3+ based NPs with inner-sphere and outer-sphere theories, respectively. In particular, we investigated the effects of τ R (the rotational time), τ M (the residence time), T ie (the electronic relation time) and τ d (the diffusion time) on longitudinal relaxivity. In the relaxation process of Gd 3+ based NPs, the inner-sphere plays a dominant role, in which τ R and τ M have a greater impact on r 1 . Based on the simulation results, we proposed a design strategy of Gd 3+ based NPs for T 1 MRI, which focuses on the rational decrease of hydrated radius, and the optimal range of the hydrated radius is about 0.8–2.5 nm. In addition, we synthesized ultrasmall Gd 2 O 3 NPs with a hydrated radius of about 2.5 nm, which have a high longitudinal relaxivity r 1 of 10.8 mM −1 s −1 at 3.0 T. Moreover, the in vivo imaging results confirm that the ultrasmall Gd 2 O 3 NPs have a good imaging effect on the tumor, and it can be a good candidate as a T 1 MRI contrast agent with high performance.
ISSN:1144-0546
1369-9261
DOI:10.1039/D1NJ00508A